Understanding Your Pathology Report: What the Terms Really Mean
If you’ve recently had a breast biopsy or breast cancer surgery, opening your pathology report can feel like reading another language.
Invasive. Grade. Receptors. Ki-67. Margins. Lymphovascular invasion.
And before the biopsy, your mammogram, ultrasound, or MRI may have included equally concerning words such as mass, irregular, spiculated, asymmetry, architectural distortion, calcifications, or dense breasts.
These terms provide important information, but no single word tells the entire story.
Understanding what these words mean—and which ones ultimately determine your diagnosis—can make your breast imaging and pathology reports much less intimidating.
First: Imaging Reports and Pathology Reports Are Different
One of the most important distinctions is the difference between an imaging report and a pathology report.
A mammogram, ultrasound, or breast MRI describes what an area looks like. A radiologist may describe its size, shape, borders, density, enhancement, or other characteristics and determine how suspicious it appears.
A pathology report describes what the cells and tissue actually are after a biopsy or surgery.
This means a term such as “spiculated mass” can sound frightening, but it is an imaging description—not a diagnosis of cancer.
The biopsy provides the diagnosis.
What Does “Mass” Mean?
A mass simply means an area of tissue that looks different from the surrounding breast tissue.
A mass can be benign or malignant.
Radiologists look at several characteristics of a mass, including its size, shape, margins or borders, density on mammography, appearance on ultrasound, and enhancement characteristics on MRI.
The combination of these features helps determine whether additional evaluation or biopsy is recommended.
What Does “Spiculated Mass” Mean?
“Spiculated” describes the border of a mass.
Instead of having a smooth, well-defined edge, a spiculated mass has thin lines radiating outward from its edges, somewhat like the rays of a star.
Spiculation is considered a suspicious imaging feature and is commonly associated with breast cancer, particularly invasive breast cancer. However, the word “spiculated” itself does not prove that something is cancer.
Certain benign conditions, including scar tissue, prior surgery, fat necrosis, and radial scars or complex sclerosing lesions, can sometimes produce a spiculated appearance.
This is why imaging findings that are sufficiently suspicious generally need tissue sampling with a biopsy.
Other Terms That May Describe the Borders of a Breast Mass
You may see several different terms describing a mass’s margins.
Circumscribed
A circumscribed mass has a clearly defined border that can be seen around most or all of the mass.
This appearance is often associated with benign findings, although the entire imaging picture still matters.
Obscured
An obscured margin means part of the edge of the mass is hidden by overlapping breast tissue.
This does not necessarily mean the border itself is abnormal—it may simply be difficult to see completely.
Microlobulated
A microlobulated margin contains multiple small lobulations or scalloped areas along the edge.
This can be more suspicious than a smoothly circumscribed border and may lead to additional evaluation.
Indistinct
An indistinct margin means the border of the mass is not clearly defined.
Because some breast cancers infiltrate into surrounding tissue rather than creating a clean border, an indistinct margin can be a suspicious feature.
Spiculated
A spiculated margin has lines extending outward from the mass into the surrounding breast tissue.
This is one of the imaging features that may raise greater concern for malignancy and frequently prompts biopsy if the diagnosis is not already known.
What Does “Irregular Mass” Mean?
“Irregular” usually refers to the shape of a mass rather than its margins.
A mass may be described as round, oval, or irregular.
An irregular shape can be suspicious, particularly when combined with other concerning features such as spiculated or indistinct margins.
But again, imaging describes appearance. Pathology determines what the tissue actually represents.
What Does “Asymmetry” Mean?
Another term you may see on a mammogram report is asymmetry.
An asymmetry means that an area of breast tissue looks different from the corresponding area in the other breast or appears more prominent than the surrounding breast tissue. It does not necessarily mean there is a true mass, and it does not mean that the finding is cancer.
Sometimes an asymmetry is simply caused by normal breast tissue overlapping on the mammogram. However, when a radiologist sees an asymmetry—particularly one that is new, changing, or otherwise concerning—it can be a clue that the area deserves a closer look.
The radiologist may recommend additional mammogram views, such as diagnostic or spot-compression images, and sometimes an ultrasound to determine whether the finding represents normal overlapping tissue, a benign breast finding, or something that needs further evaluation.
This is an important example of why being “called back” after a screening mammogram does not mean you have breast cancer. It often means the radiologist saw something that cannot be completely characterized on the initial images and needs additional pictures to better understand what is there.
What Is Architectural Distortion?
Sometimes there isn’t a clearly defined mass at all.
Instead, the normal architecture of the breast appears pulled, twisted, or distorted. Radiologists call this architectural distortion.
There are several possible causes, including previous surgery or trauma, radial scars, and breast cancer.
If there is no clear benign explanation, architectural distortion may require additional imaging or biopsy.
What Are Calcifications?
Calcifications are tiny deposits of calcium within the breast that appear as small white spots on a mammogram.
They are extremely common, especially as we get older, and most breast calcifications are benign. They can develop as part of normal aging or from benign changes in the breast, including previous inflammation, injury, surgery, or other noncancerous breast conditions.
The important issue is not simply whether calcifications are present, but what they look like and how they are arranged.
Radiologists evaluate their size, shape, number, and distribution. Some patterns have a characteristically benign appearance and require no additional evaluation.
Other calcifications may look more suspicious. For example, very small calcifications with irregular or varying shapes, particularly when they occur in certain grouped or linear patterns, may lead the radiologist to recommend additional mammogram views or a biopsy.
Certain suspicious calcification patterns can be associated with ductal carcinoma in situ (DCIS), which is stage 0, noninvasive breast cancer. In fact, DCIS is frequently detected on a mammogram because of calcifications before a person has a lump or other breast symptom.
Calcifications can also sometimes be associated with invasive breast cancer.
So seeing the word “calcifications” on your mammogram does not mean you have cancer. Most calcifications are benign. It is the appearance and pattern of the calcifications—not simply their presence—that help the radiologist determine whether further evaluation is needed.
Calcifications can be seen in two very different ways: on a mammogram, and later under the microscope if tissue is sampled. Here is what each looks like.
What Does Breast Density Mean?
Another important piece of information to look for on your mammogram report is your breast density.
In the United States, mammography facilities are federally required to include an assessment of breast density in the mammography report and to notify patients whether their breast tissue is considered dense or not dense.
Breast density describes the amount and distribution of fibroglandular tissue compared with fatty tissue in the breast. It is not something you can determine by how your breasts look or feel.
Breast density is divided into four categories:
- Almost entirely fatty
- Scattered areas of fibroglandular density
- Heterogeneously dense, which may obscure small masses
- Extremely dense, which lowers the sensitivity of mammography
The first two categories are considered not dense. The last two—heterogeneously dense and extremely dense—are considered dense breasts.
This distinction matters for two reasons. Dense breast tissue can make some cancers more difficult to see on a mammogram because both dense tissue and many breast cancers appear white. Having dense breasts is also independently associated with an increased risk of developing breast cancer.
If your mammogram says “scattered areas of fibroglandular density,” this is not considered a dense breast category. The word “fibroglandular” can sound concerning, but fibroglandular tissue is a normal component of the breast.
You may also see the term “fibroglandular tissue” used elsewhere in breast imaging reports. That term alone does not necessarily mean your breasts have been classified as dense. Look for the actual breast-density category in your mammogram report, and if you are unsure how your breast density has been classified, confirm it with your healthcare provider.
If your report says “heterogeneously dense, which may obscure small masses,” your breasts are considered dense. “Extremely dense” is also considered dense and can further lower the sensitivity of mammography.
Having dense breasts does not mean that something abnormal was found. It describes the background composition of your breast tissue.
Depending on your breast density and your other breast cancer risk factors, your healthcare provider may discuss whether additional screening beyond mammography is appropriate.
What Does BI-RADS Mean?
One of the most useful places to look when reading a breast imaging report is the final BI-RADS assessment. It is typically listed near the bottom or end of the imaging report along with the radiologist’s impression and recommendations.
BI-RADS stands for Breast Imaging Reporting and Data System. It provides a standardized way for radiologists to communicate how concerning an imaging finding appears and what should happen next.
In simplified terms:
BI-RADS 0 means the study is incomplete and additional imaging or prior images are needed.
BI-RADS 1 means the examination is negative.
BI-RADS 2 means there is a benign finding.
BI-RADS 3 means the finding is probably benign and short-term follow-up imaging is generally recommended.
BI-RADS 4 means the finding is suspicious and biopsy should be considered. BI-RADS 4 may be further divided into 4A, 4B, and 4C based on the level of suspicion.
BI-RADS 5 means the finding is highly suggestive of malignancy and tissue diagnosis is strongly recommended.
BI-RADS 6 is used when a biopsy has already proven that cancer is present.
Importantly, BI-RADS is an imaging assessment. It is not the same thing as a breast cancer stage.
Now Comes the Pathology Report
Once tissue has been obtained through a biopsy or surgery, a pathologist examines it under a microscope and may perform additional laboratory testing.
This is where the actual diagnosis is established.
Several pieces of information in a pathology report help your oncology team understand what type of breast cancer is present and how it may behave.
In Situ vs. Invasive Breast Cancer
One of the first distinctions is whether the abnormal cells are in situ or invasive.
Ductal Carcinoma in Situ (DCIS)
DCIS is considered stage 0 breast cancer.
The abnormal cells are contained within the milk ducts and have not invaded through the duct wall into the surrounding breast tissue.
Invasive Breast Cancer
“Invasive” means the cancer cells have moved beyond the structure where they began and invaded the surrounding breast tissue.
The most common type is invasive ductal carcinoma, now also commonly called invasive carcinoma of no special type.
Another important type is invasive lobular carcinoma, which begins in the breast lobules and can sometimes have different growth and imaging patterns.
What Does Tumor Grade Mean?
Grade describes how abnormal the cancer cells look under the microscope and provides information about how aggressively they may behave.
Breast cancers are generally assigned a grade from 1 to 3.
Grade 1 cancers tend to look more similar to normal breast cells and generally grow more slowly.
Grade 2 cancers have intermediate features.
Grade 3 cancers look more abnormal and generally have a higher growth rate.
Grade is not the same as stage.
A patient can have a small stage I cancer that is grade 3, or a more advanced cancer that is grade 1 or 2.
What Do ER and PR Mean?
ER stands for estrogen receptor, and PR stands for progesterone receptor.
The pathology laboratory tests whether the breast cancer cells contain these hormone receptors.
If a cancer is estrogen receptor-positive (ER+), estrogen can act as a growth signal for the cancer cells.
The report may give both a percentage and an intensity of staining. For example, you might see:
- ER: 95% positive, strong intensity
- PR: 70% positive, moderate intensity
The percentage tells you how many of the tested tumor cells showed receptor staining. It does not mean that the cancer is “95% caused by estrogen.”
Hormone receptor-positive cancers may benefit from endocrine, or hormone-blocking, treatments such as tamoxifen or aromatase inhibitors.
What Does HER2 Mean?
HER2 is a protein that can promote breast cancer cell growth.
Your pathology report may evaluate HER2 using immunohistochemistry (IHC), which measures the amount of HER2 protein on the cancer cells.
Results are generally reported as:
- IHC 0: negative
- IHC 1+: traditionally HER2-negative
- IHC 2+: equivocal and usually requires additional testing
- IHC 3+: HER2-positive
If the IHC result is 2+, another test is generally performed to determine whether the HER2 gene is amplified. This is often reported as in situ hybridization (ISH) or fluorescence in situ hybridization (FISH).
In simple terms, FISH looks at whether there are extra copies, or amplification, of the HER2 gene within the cancer cells.
If HER2 is amplified by FISH, the cancer is considered HER2-positive.
If HER2 is not amplified by FISH, the cancer is considered HER2-negative, when interpreted according to current HER2 testing criteria.
So if you see words such as “HER2 amplified” or “FISH positive” on your pathology report, this generally indicates HER2-positive breast cancer. “HER2 not amplified,” “unamplified,” or “FISH negative” generally indicates HER2-negative breast cancer.
HER2 testing is particularly important because HER2-positive cancers can be treated with highly effective HER2-targeted therapies.
You may also hear the newer terms HER2-low or HER2-ultralow. These categories have become important because certain antibody-drug conjugates may be treatment options in particular clinical settings, especially metastatic breast cancer.
What Is Ki-67?
Ki-67 is a marker of cell proliferation—essentially, how many tumor cells appear to be actively dividing.
A higher Ki-67 suggests that more cells are actively proliferating.
However, Ki-67 should not be interpreted by itself. Testing methods and interpretation can vary, and treatment decisions are generally based on the complete clinical and pathological picture rather than one Ki-67 number.
What Is Lymphovascular Invasion?
Lymphovascular invasion, sometimes abbreviated LVI, means cancer cells are seen within small lymphatic or blood vessels near the tumor.
The presence of LVI can provide additional information about recurrence risk, but it does not automatically mean the cancer has spread to distant organs.
That distinction is important.
LVI is one piece of the overall pathology picture and is interpreted alongside tumor size, lymph node status, tumor biology, grade, and other factors.
What Do “Margins” Mean?
After breast surgery, the pathologist evaluates the edges of the removed tissue.
These edges are called margins.
A negative or clear margin means cancer cells are not present at the cut edge of the specimen.
A positive margin means cancer cells extend to the edge of the removed tissue.
Margin status helps the surgical team determine whether additional surgery may be recommended.
The exact definition of an adequate margin depends on whether the diagnosis is invasive cancer or DCIS and on the type of surgery performed.
What Does Lymph Node Status Mean?
If lymph nodes are removed during surgery, the pathologist examines them for cancer cells.
Your report may say something such as:
0/3 lymph nodes involved
This means three lymph nodes were examined and none contained cancer.
If cancer is identified in a lymph node, the report may further describe the size of the deposit.
Isolated tumor cells are very small clusters of cancer cells.
A micrometastasis is larger than isolated tumor cells but no larger than 2 millimeters.
A macrometastasis is larger than 2 millimeters.
Lymph node involvement is an important part of breast cancer staging and can influence treatment recommendations.
What Does Tumor Size Mean?
The pathology report usually provides the size of the invasive cancer.
Tumor size is one component of the T category used in breast cancer staging.
Importantly, the size of the entire abnormal area seen on imaging may not be the same as the size of the invasive cancer found on pathology.
For example, an area containing both DCIS and invasive cancer may look considerably larger on imaging than the invasive component ultimately measured under the microscope.
Why Can the Biopsy and Surgical Pathology Reports Be Different?
This is a common source of confusion.
A needle biopsy samples only a portion of the abnormal area. Surgery allows the pathologist to examine much more tissue.
As a result, the final surgical pathology may provide additional information or occasionally modify information from the original biopsy.
Tumor size, grade, receptor measurements, the amount of associated DCIS, lymphovascular invasion, margins, and lymph node findings may become clearer after surgery.
This does not necessarily mean someone made a mistake. Often, the surgical specimen simply provides a more complete picture.
What Determines My Breast Cancer Stage?
Breast cancer stage is not determined by one line of your pathology report.
Staging incorporates several factors, including tumor size, lymph node involvement, whether cancer has spread to distant organs, tumor grade, ER status, PR status, and HER2 status.
You may also encounter terms such as clinical stage, pathological stage, anatomic stage, and prognostic stage.
This is one reason two people with breast tumors of similar size may not necessarily have the same stage or treatment plan.
What Information Actually Determines Treatment?
Once all of the information is assembled, your oncology team looks at the entire picture.
For invasive breast cancer, some of the most important pieces may include tumor size, lymph node status, ER and PR status, HER2 status, tumor grade, menopausal status, age and overall health, genetic testing when appropriate, and genomic testing, such as an Oncotype DX recurrence score, when appropriate.
No single number tells the whole story.
A high Ki-67 does not determine treatment by itself. A positive lymph node does not tell you everything about prognosis. A spiculated mass on mammography does not establish the diagnosis.
Each piece contributes different information.
The Bottom Line
Breast imaging and pathology reports contain a tremendous amount of information, and many of the words can sound frightening when viewed without context.
A spiculated or irregular mass, asymmetry, architectural distortion, or suspicious calcifications may prompt additional imaging or a biopsy, but imaging alone cannot make the final diagnosis. A biopsy tells us what the tissue actually is.
Breast density is another important piece of your imaging report. Dense breasts are common and do not mean that cancer is present, but they can make some cancers more difficult to see on mammography and are also associated with an increased risk of developing breast cancer.
If breast cancer is found, the pathology report then helps define the type of cancer, grade, hormone receptors, HER2 status, tumor size, lymphovascular invasion, margins, lymph node involvement, and other characteristics that help guide treatment.
Rather than focusing on one alarming word or number, try to understand how the different pieces fit together.
The goal is not simply to read your imaging or pathology report.
It is to understand what the report means for you.
This article is for educational and supportive purposes only and is not intended to provide medical advice, diagnosis, or treatment. Imaging and pathology findings should be reviewed with your licensed healthcare team, who can interpret them in the context of your individual circumstances.
Related Reading
- Spiculated Mass vs. Benign Tumor: What’s the Difference?
- How Long Does It Take to Get Breast Biopsy Results?
- Stage 1 to Stage 4: What Cancer Staging Really Means for your Treatment
Worried About the Cost of a Session?
We never want cost to be the reason someone faces a breast cancer diagnosis without support. If a session is not within reach for you right now, email us at info@myfriendmd.com and we will do what we can to help.
